GO:0030308 negative regulation of cell growth: Signaling Pathways, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0030308 (negative regulation of cell growth) describes any biological process that stops, prevents, or reduces the frequency, rate, extent, or direction of cell growth [1,3].
• It is a biological_process term that operates across kingdoms, from plant cambium and leaf margin control to mammalian tissue homeostasis and cancer suppression [2,5,6].
• Key molecular brakes include Dickkopf-3 (DKK3), which inhibits prostate cell growth and morphogenesis, and the TREM2+ macrophage-derived cytokine Oncostatin M, which maintains hair follicle stem cell quiescence [1,3].
• Dysregulation of negative growth control is central to cancer, as shown by USP27X-mediated Cyclin D1 stabilization driving proliferation and tumor growth.
• Pathway activation, such as Wnt signaling in chordoma cells, can suppress growth and offers a therapeutic handle for tumors dependent on growth factor signaling.
• CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of candidate negative growth regulators in relevant cell types [1,3,7].
Description
Negative regulation of cell growth (GO:0030308) is the biological process that stops, prevents, or reduces the frequency, rate, extent, or direction of cell growth [1,3]. It is a fundamental counterbalance to proliferative signaling and is essential for tissue homeostasis, development, and tumor suppression. Unlike terms that describe a single molecular brake, GO:0030308 encompasses any mechanism, including secreted factors, transcription factors, and intracellular signaling cascades, that restrains cell growth [1,2,3]. Researchers study this term because loss of negative growth control is a hallmark of cancer and other proliferative disorders, and because understanding these brakes can reveal therapeutic targets [7,8]. The process is conserved across eukaryotes: in plants, transcription factors such as PagMYB31 and TCP20 coordinate growth repression with developmental patterning [2,5], while in mammals, immune-derived signals like Oncostatin M maintain stem cell quiescence. This article synthesizes authoritative QuickGO annotation and verified PubMed literature to provide a research-grade overview of GO:0030308, its mechanisms, key genes, disease links, and experimental models.
negative regulation of cell growth At A Glance
| GO ID | GO:0030308 |
|---|---|
| GO term | negative regulation of cell growth |
| Ontology | biological_process |
| Synonym | down regulation of cell growth; down-regulation of cell growth; downregulation of cell growth; inhibition of cell growth |
| Major function | Stops, prevents, or reduces the frequency, rate, extent, or direction of cell growth |
| Biological context | Development, tissue homeostasis, stem cell quiescence, tumor suppression |
| Representative regulators | DKK3, Oncostatin M, PagMYB31, TCP20, CUC3, USP27X, Cyclin D1 |
| Cross-species relevance | Plants (Arabidopsis, poplar) and mammals (human, mouse) |
| Disease relevance | Cancer, chordoma, prostate disease, hair growth disorders |
What Is GO:0030308?
According to the Gene Ontology, negative regulation of cell growth (GO:0030308) is any process that stops, prevents, or reduces the frequency, rate, extent, or direction of cell growth. It is a biological_process term with synonyms including down regulation of cell growth, down-regulation of cell growth, downregulation of cell growth, and inhibition of cell growth. The term covers both direct inhibition of growth machinery and upstream signaling that ultimately restrains cell size or proliferation.
Why Is negative regulation of cell growth Important in Cell Biology?
Negative regulation of cell growth is essential for normal development and tissue homeostasis, and its failure contributes to cancer and other proliferative diseases [7,8]. Understanding the mechanisms that restrain growth provides targets for therapeutic intervention and biomarkers for disease progression [3,7].
• Maintains stem cell quiescence, as shown by TREM2+ dermal macrophages secreting Oncostatin M to inhibit hair follicle stem cell activation.
• Controls organ size and patterning, exemplified by CUC3 shaping leaf margins and TCP20 linking growth and cell division in Arabidopsis [5,6].
• Regulates cambium activity and xylem development in poplar through PagMYB31.
• Suppresses prostate cell growth and morphogenesis via Dickkopf-3.
• Restrains cancer cell proliferation; loss of negative regulation promotes tumor growth.
• Can be engaged therapeutically, as Wnt pathway activation suppresses chordoma cell growth.
• Modulates bacterial cell size and growth rate through envelope stress responses.
• Provides a conceptual framework for identifying tumor suppressors and growth-inhibitory signals [3,7].
What Happens During negative regulation of cell growth?
Initiation by extracellular or intracellular signals
In simple terms: A brake signal is received by the cell.
Negative regulation of cell growth can be initiated by secreted factors such as Oncostatin M from TREM2+ dermal macrophages, which acts on hair follicle stem cells to maintain quiescence and inhibit hair growth. Similarly, Dickkopf-3 (DKK3) acts as an extracellular signal that regulates prostate cell growth and morphogenesis. In plants, transcription factors such as PagMYB31 and TCP20 integrate developmental cues to negatively regulate growth-related processes [2,5].
Signal transduction and transcriptional reprogramming
In simple terms: The brake signal is relayed to the nucleus to change gene expression.
Upon reception, signaling cascades modulate transcription factors that reprogram growth-related genes. For example, CUC3 spatiotemporally controls cell growth to shape leaf margins, demonstrating transcriptional control of growth repression. In poplar, PagMYB31 positively regulates cambium activity while negatively regulating xylem development, illustrating dual roles in growth control.
Cell cycle and growth machinery inhibition
In simple terms: The cell's growth engine is slowed or stopped.
Negative regulation often converges on the cell cycle machinery. Cyclin D1 degradation is regulated by ubiquitin-specific protease 27X (USP27X), and this degradation is critical for restraining cancer cell proliferation and tumor growth. Activation of the Wnt pathway suppresses growth of MUG-Chor1 chordoma cells, indicating that growth-inhibitory signals can override proliferative drivers.
Outcomes: quiescence, reduced size, or altered morphogenesis
In simple terms: The cell either stops growing, grows more slowly, or changes shape.
The ultimate outcomes of negative regulation of cell growth include stem cell quiescence, reduced cell size, and altered tissue morphogenesis. Oncostatin M maintains hair follicle stem cell quiescence, while DKK3 regulates prostate cell growth and morphogenesis. In bacteria, activation of a cell envelope stress response modulates cell size and growth rate, showing that negative growth regulation is evolutionarily widespread.
Key Genes Involved in GO:0030308 negative regulation of cell growth
The following genes and proteins have been experimentally linked to negative regulation of cell growth (GO:0030308) in the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TREM2 | Marker of dermal macrophages that secrete Oncostatin M to maintain hair follicle stem cell quiescence | Stem cell quiescence and hair growth inhibition |
| OSM (Oncostatin M) | Cytokine that inhibits hair growth and maintains stem cell quiescence | Paracrine negative regulation of growth |
| PagMYB31 | Transcription factor that positively regulates cambium activity and negatively regulates xylem development | Wood formation and growth control in poplar |
| DKK3 | Secreted protein that regulates prostate cell growth and morphogenesis | Prostate development and tumor suppression |
| TCP20 | Transcription factor linking growth and cell division control pathways | Plant growth regulation |
| CUC3 | Transcription factor controlling spatiotemporal cell growth to shape leaf margins | Organ morphogenesis |
| USP27X | Deubiquitinase regulating Cyclin D1 degradation | Cancer cell proliferation and tumor growth |
| CCND1 (Cyclin D1) | Cell cycle regulator whose degradation restrains proliferation | Cancer proliferation and tumor growth |
| Wnt pathway components | Signaling cascade whose activation suppresses chordoma cell growth | Chordoma growth inhibition |
| Cell envelope stress response genes | Bacterial genes modulating cell size and growth rate | Bacterial growth control |
How Is negative regulation of cell growth Regulated?
Negative regulation of cell growth is itself regulated at multiple levels. Extracellular signals such as Oncostatin M from TREM2+ macrophages maintain stem cell quiescence, while DKK3 regulates prostate cell growth and morphogenesis. Intracellularly, ubiquitin-specific protease 27X (USP27X) controls Cyclin D1 degradation, and this regulation is critical for restraining cancer cell proliferation and tumor growth. Pathway-level control is exemplified by Wnt activation suppressing chordoma cell growth. In plants, transcription factors PagMYB31, TCP20, and CUC3 integrate developmental and environmental cues to negatively regulate growth [2,5,6]. In bacteria, activation of a cell envelope stress response modulates cell size and growth rate.
negative regulation of cell growth and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| USP27X | Cancer cell proliferation and tumor growth | Knockout or overexpression in cancer cell lines |
| CCND1 | Tumor growth | Point mutation or knock-in of degradation-resistant Cyclin D1 |
| DKK3 | Prostate disease and morphogenesis | Knockout in prostate cell lines or organoids |
| TREM2/OSM | Hair growth disorders and stem cell quiescence | Conditional knockout in mouse skin |
| Wnt pathway components | Chordoma | Wnt activation in chordoma cell lines |
Cancer and tumor growth
Loss of negative regulation of cell growth is a key feature of cancer. USP27X-mediated regulation of Cyclin D1 degradation is critical for cancer cell proliferation and tumor growth, and its disruption can lead to unchecked proliferation. In chordoma, activation of the Wnt pathway suppresses growth of MUG-Chor1 cells, suggesting that restoring negative growth signals can inhibit tumor growth.
Prostate disease and morphogenesis
Dickkopf-3 (DKK3) regulates prostate cell growth and morphogenesis, and its dysregulation may contribute to prostate disease. This highlights the role of secreted negative growth regulators in tissue homeostasis.
Hair growth disorders and stem cell quiescence
TREM2+ dermal macrophages secrete Oncostatin M to maintain hair follicle stem cell quiescence and inhibit hair growth. This mechanism links immune cells to negative regulation of cell growth in the skin and may be relevant to hair loss or excess hair growth conditions.
Bacterial growth and stress responses
Modulation of bacterial cell size and growth rate via activation of a cell envelope stress response demonstrates that negative regulation of growth is also important in prokaryotes, with implications for antibiotic tolerance and pathogenesis.
From negative regulation of cell growth-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for negative regulation of cell growth? | CRISPR knockout in relevant cell line [3,7] |
| Does a specific point mutation abolish growth suppression? | Point mutation knock-in |
| Does a secreted factor inhibit growth in vivo? | Overexpression or knock-in of the factor |
| Does a transcription factor directly regulate growth genes? | Tagged knock-in for ChIP-seq [2,5] |
| Can restoring a negative regulator suppress tumor growth? | Overexpression in cancer cells |
| Does a bacterial gene modulate cell size? | Knockout in bacterial strain |
How to Study the negative regulation of cell growth Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screen | Gene essentiality for growth suppression | Identify negative growth regulators |
| RNA-seq | Transcriptional changes | Downstream effects of regulators [2,5] |
| Cycloheximide chase | Protein stability | Cyclin D1 degradation |
| Ubiquitination assay | Post-translational modification | USP27X activity |
| Live imaging | Cell growth and morphogenesis | Leaf margin or organoid shape [3,6] |
| ChIP-seq | Transcription factor binding | PagMYB31 or TCP20 targets [2,5] |
| Bacterial growth curve | Cell size and growth rate | Envelope stress response |
CRISPR knockout screens
Genome-wide CRISPR knockout screens can identify genes whose loss increases cell growth, revealing negative regulators.
Transcriptional profiling (RNA-seq)
RNA-seq after perturbation of candidate regulators can reveal downstream growth-related gene expression changes [2,5].
Protein degradation assays
Cyclin D1 degradation can be monitored by cycloheximide chase or ubiquitination assays to study USP27X function.
Imaging and morphogenesis assays
Live imaging of leaf margins or prostate organoids can quantify growth and morphogenesis defects [3,6].
How CRISPR Can Be Used to Study GO:0030308 negative regulation of cell growth
Knockout
CRISPR knockout of candidate negative regulators such as USP27X or DKK3 can test whether they are required to restrain cell growth [3,7].
Point Mutation
Point mutations can be introduced into genes like CCND1 to prevent its degradation, testing the importance of specific residues in growth control.
Knock-in
Knock-in of tagged versions of transcription factors such as PagMYB31 or TCP20 enables ChIP-seq and localization studies [2,5].
Overexpression
Overexpression of negative regulators like DKK3 or Wnt pathway components can suppress growth in cancer cell lines [3,8].
How EDITGENE Supports negative regulation of cell growth Research
Researchers studying negative regulation of cell growth-related genes often need to determine whether a candidate gene is causally involved in restraining proliferation or growth. EDITGENE provides comprehensive CRISPR services to enable such functional studies.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of cell growth research.
Frequently Asked Questions About negative regulation of cell growth
What is negative regulation of cell growth (GO:0030308)?
It is any biological process that stops, prevents, or reduces the frequency, rate, extent, or direction of cell growth [1,3].
What genes are involved in negative regulation of cell growth?
Key genes include TREM2, OSM, DKK3, PagMYB31, TCP20, CUC3, USP27X, and CCND1 [1,2,3,5,6,7].
How does Oncostatin M inhibit hair growth?
TREM2+ dermal macrophages secrete Oncostatin M to maintain hair follicle stem cell quiescence and inhibit hair growth.
What is the role of DKK3 in prostate cell growth?
DKK3 regulates prostate cell growth and morphogenesis.
How is Cyclin D1 degradation linked to cancer growth?
USP27X regulates Cyclin D1 degradation, which is critical for cancer cell proliferation and tumor growth.
Can Wnt pathway activation suppress tumor growth?
Yes, activation of the Wnt pathway suppresses growth of MUG-Chor1 chordoma cells.
What model systems are used to study negative regulation of cell growth?
Models include CRISPR knockout cell lines, mouse models, plant systems, and bacterial strains [1,2,3,4,5,6,7,8].
What is the difference between negative regulation of cell growth and apoptosis?
Negative regulation of cell growth reduces growth rate or extent without necessarily causing cell death, whereas apoptosis is programmed cell death [1,3].
How do plant transcription factors control growth?
PagMYB31 negatively regulates xylem development, TCP20 links growth and cell division, and CUC3 shapes leaf margins [2,5,6].
What CRISPR services are available for studying growth regulation?
EDITGENE offers knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services [1,3,7].
Conclusion
Negative regulation of cell growth (GO:0030308) is a fundamental biological process that restrains growth across species, from plants to mammals. Its dysregulation contributes to cancer and other proliferative diseases, making it a rich area for therapeutic targeting [7,8]. By leveraging CRISPR models and multi-omics approaches, researchers can uncover new mechanisms and translate them into clinical advances.
References
- 1. Wang ECE et al.. 2019. A Subset of TREM2(+) Dermal Macrophages Secretes Oncostatin M to Maintain Hair Follicle Stem Cell Quiescence and Inhibit Hair Growth.. Cell Stem Cell 24(4):654-669.e6 PMID: 30930146
- 2. Zhang Y et al.. 2024. Transcription factor PagMYB31 positively regulates cambium activity and negatively regulates xylem development in poplar.. Plant Cell 36(5):1806-1828 PMID: 38339982
- 3. Kawano Y et al.. 2006. Regulation of prostate cell growth and morphogenesis by Dickkopf-3.. Oncogene 25(49):6528-37 PMID: 16751809
- 4. Miguel A et al.. 2025. Modulation of bacterial cell size and growth rate via activation of a cell envelope stress response.. mBio 16(11):e0228125 PMID: 40980883
- 5. Li C et al.. 2005. Arabidopsis TCP20 links regulation of growth and cell division control pathways.. Proc Natl Acad Sci U S A 102(36):12978-83 PMID: 16123132
- 6. Serra L et al.. 2020. Spatiotemporal control of cell growth by CUC3 shapes leaf margins.. Development 147(6) PMID: 32094116
- 7. Alam S et al.. 2022. Regulation of Cyclin D1 Degradation by Ubiquitin-Specific Protease 27X Is Critical for Cancer Cell Proliferation and Tumor Growth.. Mol Cancer Res 20(12):1751-1762 PMID: 36001804
- 8. Şişli HB et al.. 2023. Activation of Wnt Pathway Suppresses Growth of MUG-Chor1 Chordoma Cell Line.. Cell Biochem Biophys 81(4):823-837 PMID: 37751039
